| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5289632
Max Phase: Preclinical
Molecular Formula: C28H34ClN3O
Molecular Weight: 427.59
Associated Items:
Representations
Canonical SMILES: CCN1CCc2c(c3ccccc3n2CC(O)Cn2c3c(c4ccccc42)CCCC3)C1.Cl
Standard InChI: InChI=1S/C28H33N3O.ClH/c1-2-29-16-15-28-24(19-29)23-11-5-8-14-27(23)31(28)18-20(32)17-30-25-12-6-3-9-21(25)22-10-4-7-13-26(22)30;/h3,5-6,8-9,11-12,14,20,32H,2,4,7,10,13,15-19H2,1H3;1H
Standard InChI Key: OLDAQKWWBFGEIZ-UHFFFAOYSA-N
Associated Targets(Human)
Butyrylcholinesterase 7174 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 427.59 | Molecular Weight (Monoisotopic): 427.2624 | AlogP: 4.91 | #Rotatable Bonds: 5 |
| Polar Surface Area: 33.33 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 7.41 | CX LogP: 5.04 | CX LogD: 4.73 |
| Aromatic Rings: 4 | Heavy Atoms: 32 | QED Weighted: 0.49 | Np Likeness Score: -0.63 |
References
| 1. Dai J, Dan W, Zhang Y, Wang J.. (2018) Recent developments on synthesis and biological activities of γ-carboline., 157 [PMID:30103193] [10.1016/j.ejmech.2018.08.015] |
Source
Source(1):